Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents.
作者信息
Goltz Jeffrey Samuel, Rice Timothy Reynolds
机构信息
Psychiatry, Mount Sinai St. Luke's-West Hospital, New York City, NY, USA.
Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
出版信息
Front Psychiatry. 2017 Apr 19;8:59. doi: 10.3389/fpsyt.2017.00059. eCollection 2017.
Abstract
摘要
相似文献
1
Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents.评论：二甲双胍治疗儿童和青少年非典型抗精神病药物治疗起始相关体重增加的随机、双盲、安慰剂对照试验。
Front Psychiatry. 2017 Apr 19;8:59. doi: 10.3389/fpsyt.2017.00059. eCollection 2017.
2
A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.一项关于二甲双胍治疗儿童和青少年非典型抗精神病药物治疗引发体重增加的随机、双盲、安慰剂对照试验。
Am J Psychiatry. 2006 Dec;163(12):2072-9. doi: 10.1176/ajp.2006.163.12.2072.
3
A systematic review of metformin to limit weight-gain with atypical antipsychotics.二甲双胍限制非典型抗精神病药引起体重增加的系统评价。
J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Epub 2011 Mar 21.
4
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.二甲双胍治疗自闭症谱系障碍青少年使用非典型抗精神病药物引起的超重：一项随机临床试验。
JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.
5
Management of atypical antipsychotic drug-induced weight gain: focus on metformin.非典型抗精神病药物所致体重增加的管理：聚焦于二甲双胍。
Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725.
6
Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.二甲双胍用于治疗南亚地区精神分裂症或分裂情感性障碍患者抗精神病药物所致体重增加：一项双盲、随机、安慰剂对照研究。
J Psychopharmacol. 2015 Dec;29(12):1255-61. doi: 10.1177/0269881115613519. Epub 2015 Oct 28.
7
8
A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.一项针对使用抗精神病药物治疗自闭症谱系障碍的年轻人超重的二甲双胍治疗的随机、安慰剂对照试验：开放标签扩展。
J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):849-856.e6. doi: 10.1016/j.jaac.2017.07.790. Epub 2017 Aug 19.
9
Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics: a double-blind randomized placebo-controlled study.在接受非典型抗精神病药物治疗的精神分裂症患者中，与安慰剂相比，辅助使用α-硫辛酸在12周时可减少体重增加：一项双盲随机安慰剂对照研究。
Int Clin Psychopharmacol. 2016 Sep;31(5):265-74. doi: 10.1097/YIC.0000000000000132.
10
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.二甲双胍治疗首发精神分裂症女性抗精神病药所致闭经和体重增加的双盲、随机、安慰剂对照研究。
Am J Psychiatry. 2012 Aug;169(8):813-21. doi: 10.1176/appi.ajp.2012.11091432.
引用本文的文献
1
Second generation antipsychotic-induced weight gain in youth with autism spectrum disorders: a brief review of mechanisms, monitoring practices, and indicated treatments.第二代抗精神病药物导致的自闭症谱系障碍青少年体重增加：机制、监测方法及相关治疗简述
Int J Dev Disabil. 2019 Jul 14;67(3):159-167. doi: 10.1080/20473869.2019.1638583.
本文引用的文献
1
Psychological consequences of childhood obesity: psychiatric comorbidity and prevention.儿童肥胖的心理后果：精神疾病共病与预防
Adolesc Health Med Ther. 2016 Nov 14;7:125-146. doi: 10.2147/AHMT.S101631. eCollection 2016.
2
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.二甲双胍治疗自闭症谱系障碍青少年使用非典型抗精神病药物引起的超重：一项随机临床试验。
JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.
3
Metformin in an Adolescent with Significant Weight Gain.二甲双胍用于一名体重显著增加的青少年患者
J Child Adolesc Psychopharmacol. 2015 Sep;25(7):589-92. doi: 10.1089/cap.2015.29022.bjc.
4
Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.二甲双胍用于抗精神病药物治疗相关的体重增加和代谢异常：随机安慰剂对照试验的荟萃分析。
J Clin Psychopharmacol. 2015 Oct;35(5):499-509. doi: 10.1097/JCP.0000000000000392.
5
Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.改善抗精神病药物儿童治疗的代谢参数（IMPACT）研究：原理、设计和方法。
Child Adolesc Psychiatry Ment Health. 2013 Aug 15;7(1):31. doi: 10.1186/1753-2000-7-31.
6
Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.抗精神病药治疗儿童和青少年的体重增加和体重指数升高：批判性综述。
Eur Child Adolesc Psychiatry. 2013 Aug;22(8):457-79. doi: 10.1007/s00787-013-0399-5. Epub 2013 Mar 17.
7
Associations between obesity and comorbid mental health, developmental, and physical health conditions in a nationally representative sample of US children aged 10 to 17.在一个具有全国代表性的美国 10 至 17 岁儿童样本中，肥胖与合并的心理健康、发育和身体健康状况之间的关联。
Acad Pediatr. 2013 Jan-Feb;13(1):6-13. doi: 10.1016/j.acap.2012.10.007. Epub 2012 Nov 30.
8
Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.非药物干预对抗精神病药相关体重增加和代谢异常的急性和维持效果：随机对照试验的荟萃分析比较。
Schizophr Res. 2012 Sep;140(1-3):159-68. doi: 10.1016/j.schres.2012.03.017. Epub 2012 Jul 3.
9
A systematic review of metformin to limit weight-gain with atypical antipsychotics.二甲双胍限制非典型抗精神病药引起体重增加的系统评价。
J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Epub 2011 Mar 21.
10
Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.二甲双胍对肥胖胰岛素抵抗儿童体重和身体成分的影响：一项随机临床试验。
Diabetes. 2011 Feb;60(2):477-85. doi: 10.2337/db10-1185. Epub 2011 Jan 12.
Zotero 插件